COMP <GO>
BON vs JNJ // GROSS PROFIT MARGIN
Bon Natural Life Limited (Class A) (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: BON 0
— JNJ 8
▲ GROSS PROFIT MARGIN LEADER: JNJ
LAST: $1.14 (+0.89%) • MKT CAP: $9.2M
gross-margins
20.80%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BON VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BON | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 20.80% | 67.90% | -47.10 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 25.50% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.46% | 2.97% | -1.51 | JNJ | /fcf-yield <GO> |
| Operating Margin | -8.70% | 34.70% | -43.40 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -10.70% | 28.50% | -39.20 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | -21.70% | 6.00% | -27.70 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.59 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.5 | 62.1 | -16.60 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.2M | $662.49B | -$662.48B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BON REV | JNJ REV | BON GROSS % | JNJ GROSS % | BON FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.7M | $94.19B | 20.8% | 67.9% | $134.3K | $19.70B |
| FY 2024 | $23.8M | $88.82B | 29.8% | 69.1% | -$7.7M | $19.84B |
| FY 2023 | $29.5M | $85.16B | — | — | -$616.9K | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BON // BETA —
JNJ // BETA 1.08